Phase 3 Results of Bepirovirsen Treatment for Chronic Hepatitis B Virus Infection
Jinlin Hou, Seng‐Gee Lim, Maria Buti, M-F Yuen et autres
15 citationsNew England Journal of Medicine
Geoff Quinn
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
6Publications signalées
297Citations signalées
1Affiliations récentes
Institutions déclarées
Domaines associés
Hepatitis C virus researchHepatitis B Virus StudiesHepatitis Viruses Studies and EpidemiologyInfluenza Virus Research StudiesLiver Disease Diagnosis and Treatment
Publications récentes
TOP-268 Up to 2 years’ functional cure in response to bepirovirsen therapy in B-Clear Not-on-NA responders: B-Sure third report
Seng Gee Lim, Manuela Arbune, Masanori Atsukawa, Stuart Flanagan et autres
1 citationJournal of Hepatology
B-Clear Phase 2b Study Design: Establishing the Efficacy and Safety of Bepirovirsen in Patients with Chronic Hepatitis B Virus Infection
Jennifer Cremer, Robert C. Elston, Fiona Campbell, Stuart Kendrick et autres
3 citationsAdvances in Therapy
Analysis of HBV genotype association to bepirovirsen treatment response in patients with chronic HBV infection (Phase 2b B-Clear study)
Jérôme Bouquet, Robert C. Elston, Phil Yates, Shihyun You et autres
0 citationsJournal of Hepatology
Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection
Man‐Fung Yuen, Seng Gee Lim, Robert Pleśniak, Keiji Tsuji et autres
274 citationsNew England Journal of Medicine
Efficacy and safety of bepirovirsen in patients with chronic hepatitis B virus infection not on stable nucleos (t)ide analogue therapy: interim results from the randomised phase 2b B-Clear study
Seng Gee Lim, Cristina Pojoga, Harry L.A. Janssen, Д. А. Гусев et autres
4 citationsJournal of Hepatology
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.